| 000 | 01670 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250512023522.0 | ||
| 264 | 0 | _c19870715 | |
| 008 | 198707s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(87)90648-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSoulillou, J P | |
| 245 | 0 | 0 |
_aPrevention of rejection of kidney transplants by monoclonal antibody directed against interleukin 2. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJun 1987 |
||
| 300 |
_a1339-42 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntilymphocyte Serum _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft Rejection |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _ximmunology |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Immunologic _ximmunology |
| 650 | 0 | 4 | _aReceptors, Interleukin-2 |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aPeyronnet, P | |
| 700 | 1 | _aLe Mauff, B | |
| 700 | 1 | _aHourmant, M | |
| 700 | 1 | _aOlive, D | |
| 700 | 1 | _aMawas, C | |
| 700 | 1 | _aDelaage, M | |
| 700 | 1 | _aHirn, M | |
| 700 | 1 | _aJacques, Y | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8546 _gp. 1339-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(87)90648-9 _zAvailable from publisher's website |
| 999 |
_c2890300 _d2890300 |
||